Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysis
Introduction The increase in the number of patients with uncontrolled type 2 diabetes mellitus (T2DM) is in need of effective management interventions. However, research to date has been limited to the evaluation of the outcomes of community pharmacists alone. Therefore, the aim of the study protoco...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-10-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/13/10/e072960.full |
_version_ | 1827120373542420480 |
---|---|
author | Qingwei Zhao Hongmei Wang Dongsheng Hong Yiqing Weng Binghui Miao Mengdie Zhang Beijia Wang |
author_facet | Qingwei Zhao Hongmei Wang Dongsheng Hong Yiqing Weng Binghui Miao Mengdie Zhang Beijia Wang |
author_sort | Qingwei Zhao |
collection | DOAJ |
description | Introduction The increase in the number of patients with uncontrolled type 2 diabetes mellitus (T2DM) is in need of effective management interventions. However, research to date has been limited to the evaluation of the outcomes of community pharmacists alone. Therefore, the aim of the study protocol is to compare the effects of clinical pharmacist-led intervention strategies for the management of T2DM in the outpatient settings.Method and analysis The study will collect and analyse data applying standard Cochrane methodological procedures. A search for eligible studies and ongoing trials will be conducted using PubMed, Embase, Medline (via Ovid), EBSCO (via Ovid), Lippincott Williams & Wilkins (LWW) Journals (via Ovid), ProQuest Health and Medical Complete, and ClinicalTrials.gov (clinicaltrials.gov) from database inception to December 2023. Clinical and health outcomes will be measured using both glycaemic control related indicators (eg, glycated haemoglobin, fasting blood glucose, postprandial glucose) and general indicators (eg, adherence, disease management and health-related quality of life). The meta-analysis will conduct pairwise meta-analysis using random effects models and network meta-analysis (NMA) employing the Bayesian hierarchical model. The visualisation and statistical analysis will be carried out using RevMan, R Studio and ADDIS. Additionally, we will evaluate the certainty of the evidence by using Grading of Recommendations Assessment, Development and Evaluation system.Ethics and dissemination There will be no primary data collection from NMA participants, and there is no requirement for formal ethical review. Our aim is to present the results of this NMA in a peer-reviewed scientific journal, at conferences, and in the mainstream media.PROSPERO registration number CRD42022355368. |
first_indexed | 2024-03-11T13:25:51Z |
format | Article |
id | doaj.art-d5237f251bf64af481fbf8ab62bbdc08 |
institution | Directory Open Access Journal |
issn | 2044-6055 |
language | English |
last_indexed | 2025-03-20T13:36:13Z |
publishDate | 2023-10-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | BMJ Open |
spelling | doaj.art-d5237f251bf64af481fbf8ab62bbdc082024-09-12T08:15:10ZengBMJ Publishing GroupBMJ Open2044-60552023-10-01131010.1136/bmjopen-2023-072960Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysisQingwei Zhao0Hongmei Wang1Dongsheng Hong2Yiqing Weng3Binghui Miao4Mengdie Zhang5Beijia Wang62 Department of Clinical Pharmacy, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou, China1 Department of Social Medicine of School of Public Health and Department of Pharmacy of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China2 Department of Clinical Pharmacy, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou, China1 Department of Social Medicine of School of Public Health and Department of Pharmacy of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Social Medicine of School of Public Health and Department of Pharmacy of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Social Medicine of School of Public Health and Department of Pharmacy of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China1 Department of Social Medicine of School of Public Health and Department of Pharmacy of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaIntroduction The increase in the number of patients with uncontrolled type 2 diabetes mellitus (T2DM) is in need of effective management interventions. However, research to date has been limited to the evaluation of the outcomes of community pharmacists alone. Therefore, the aim of the study protocol is to compare the effects of clinical pharmacist-led intervention strategies for the management of T2DM in the outpatient settings.Method and analysis The study will collect and analyse data applying standard Cochrane methodological procedures. A search for eligible studies and ongoing trials will be conducted using PubMed, Embase, Medline (via Ovid), EBSCO (via Ovid), Lippincott Williams & Wilkins (LWW) Journals (via Ovid), ProQuest Health and Medical Complete, and ClinicalTrials.gov (clinicaltrials.gov) from database inception to December 2023. Clinical and health outcomes will be measured using both glycaemic control related indicators (eg, glycated haemoglobin, fasting blood glucose, postprandial glucose) and general indicators (eg, adherence, disease management and health-related quality of life). The meta-analysis will conduct pairwise meta-analysis using random effects models and network meta-analysis (NMA) employing the Bayesian hierarchical model. The visualisation and statistical analysis will be carried out using RevMan, R Studio and ADDIS. Additionally, we will evaluate the certainty of the evidence by using Grading of Recommendations Assessment, Development and Evaluation system.Ethics and dissemination There will be no primary data collection from NMA participants, and there is no requirement for formal ethical review. Our aim is to present the results of this NMA in a peer-reviewed scientific journal, at conferences, and in the mainstream media.PROSPERO registration number CRD42022355368.https://bmjopen.bmj.com/content/13/10/e072960.full |
spellingShingle | Qingwei Zhao Hongmei Wang Dongsheng Hong Yiqing Weng Binghui Miao Mengdie Zhang Beijia Wang Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysis BMJ Open |
title | Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysis |
title_full | Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysis |
title_fullStr | Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysis |
title_full_unstemmed | Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysis |
title_short | Effects of pharmacist-led interventions on glycaemic control, adherence, disease management and health-related quality of life in patients with type 2 diabetes: a protocol for a network meta-analysis |
title_sort | effects of pharmacist led interventions on glycaemic control adherence disease management and health related quality of life in patients with type 2 diabetes a protocol for a network meta analysis |
url | https://bmjopen.bmj.com/content/13/10/e072960.full |
work_keys_str_mv | AT qingweizhao effectsofpharmacistledinterventionsonglycaemiccontroladherencediseasemanagementandhealthrelatedqualityoflifeinpatientswithtype2diabetesaprotocolforanetworkmetaanalysis AT hongmeiwang effectsofpharmacistledinterventionsonglycaemiccontroladherencediseasemanagementandhealthrelatedqualityoflifeinpatientswithtype2diabetesaprotocolforanetworkmetaanalysis AT dongshenghong effectsofpharmacistledinterventionsonglycaemiccontroladherencediseasemanagementandhealthrelatedqualityoflifeinpatientswithtype2diabetesaprotocolforanetworkmetaanalysis AT yiqingweng effectsofpharmacistledinterventionsonglycaemiccontroladherencediseasemanagementandhealthrelatedqualityoflifeinpatientswithtype2diabetesaprotocolforanetworkmetaanalysis AT binghuimiao effectsofpharmacistledinterventionsonglycaemiccontroladherencediseasemanagementandhealthrelatedqualityoflifeinpatientswithtype2diabetesaprotocolforanetworkmetaanalysis AT mengdiezhang effectsofpharmacistledinterventionsonglycaemiccontroladherencediseasemanagementandhealthrelatedqualityoflifeinpatientswithtype2diabetesaprotocolforanetworkmetaanalysis AT beijiawang effectsofpharmacistledinterventionsonglycaemiccontroladherencediseasemanagementandhealthrelatedqualityoflifeinpatientswithtype2diabetesaprotocolforanetworkmetaanalysis |